Skyepharma Production SAS

Skyepharma is a key player in drug development and delivery of oral technologies serving the global pharmaceutical, biotech and consumer health industries. Since 1996, we help our clients to offer the best drug for the benefit of the patient. In 2016, Skyepharma became the oral business Unit of the Vectura Group of Companies (www.vectura.com) and transformed into a fully integrated french CDMO [see our History]. In June 2021, Skyepharma becomes a newly independent CDMO looking to further growth. Skyepharma is deeply committed to performance management and value creation for its clients. Our services are continuously improved to offer state-of-the-art global development, manufacturing and packaging services. Our partners can rely on our agility and scientific expertise resulting in accelerated time to market and maximized value across all pharmaceutical lifecycle stages.